Biotech Archives - Page 688 of 795

2 minute read

AC Immune Partner LMI Progresses Tau PET Tracer PI-2620 Into Late-Stage Development In Alzheimer’s Disease

September 26, 7:32 AM

AC Immune’s Tau PET tracer moves closer to becoming a next generation diagnostic for Alzheimer’s Disease (AD) AC Immune to receive a milestone payment from LMI for progress into late-stage product

ACIU

2 minute read

Moderna Seeks FDA Approval For Updated COVID-19 Shot For Kids, But Scrambles Supply Challenges

By Vandana Singh

September 26, 7:25 AM

Last week, Moderna Inc (NASDAQ: MRNA) said it asked the FDA to authorize the use of its updated booster shot in children ages 6 to 17. The company expects to complete a request for the use of the booster in children six months through 5 years later this year.

BNTX

1 minute read

Anebulo Pharmaceuticals Announces Interim Data For ANEB-001 From Part B Of Its Phase 2 Clinical Trial For Acute Cannabinoid Intoxication; Says Lower Doses Of ANEB-001 Reduced The Negative Effects Of Higher Doses Of THC

By Bill Haddad

September 26, 7:04 AM

Lower doses of ANEB-001 reduced the negative effects of higher doses of THC Currently exploring delayed dosing to better understand real-world conditions AUSTIN, Texas--(BUSINESS WIRE)-- Anebulo Pharmaceuticals,

ANEB

2 minute read

BD, CerTest Biotec Announce US Commercial Launch Of Monkeypox Assay

By Benzinga Newsdesk

September 26, 6:50 AM

BD (Becton, Dickinson and Company) (NYSE:BDX), a leading global medical technology company, and CerTest Biotec today announced their newly developed molecular polymerase chain reaction (PCR) assay for monkeypox virus is

BDX

1 minute read

Magic Mushrooms For Anorexia? Clinical Study Receives FDA Approval For Phase 2 Trial

By Lara Goldstein

September 25, 12:16 PM

Origin Therapeutics Holdings Inc. (CSE: ORIG), a psychedelics industry-focused investment issuer, announced that one of its portfolio companies, Xpira Pharmaceuticals, has obtained approval from the FDA for its first Investigational New Drug (IND) application for a Phase 2a psilocybin therapy clinical study for anorexia nervosa.

CSE:ORIG

1 minute read

Pfizer Resumes Dosing In Phase 3 Hemophilia Gene Therapy Trial Six Months After FDA Lifts Clinical Hold

By Vandana Singh

September 23, 12:02 PM

Pfizer Inc (NASDAQ:PFE) and its partner Sangamo Therapeutics Inc (NASDAQ:SGMO) have reopened enrollment in phase 3 AFFINE study hemophilia A gene therapy trial. …

PFE

1 minute read

After Regulatory Setback, Spectrum Pharma Secures Up To $65M In Debt Funding

By Vandana Singh

September 23, 11:25 AM

Spectrum Pharmaceuticals Inc (NASDAQ:SPPI) entered into a five-year debt financing agreement with SLR Capital Partners for a term loan…

SPPI

1 minute read

Artivion Stock Plunges Apixaban Vs. Warfarin Trial Setback, Reaffirms Annual Guidance

By Vandana Singh

September 23, 10:08 AM

Artivion Inc (NYSE:AORT) has stopped the PROACT Xa trial to determine if patients with an On-X mechanical aortic valve can be…

AORT

1 minute read

ClearPoint Neuro Secures FDA Nod For ClearPoint Prism Neuro Laser Therapy System

By Vandana Singh

September 23, 9:28 AM

ClearPoint Neuro Inc’s (NASDAQ:CLPT) Swedish partner, Clinical Laserthermia Systems (CLS), has received FDA 510(k) clearance for its laser, which the company…

CLPT

1 minute read

AstraZeneca Pulls Plug On Ionis Pharma-Partnered Cholesterol Med

By Vandana Singh

September 23, 9:12 AM

Ionis Pharmaceuticals Inc (NASDAQ:IONS) announced topline data from the Phase 2b SOLANO study of ION449 (AZD8233) for hypercholesterolemia (high cholesterol levels).…

AZN